Company intelligence / Profile preview

Yael Capital

Ownership: Private
Development stage: Other

Overview

Yael Capital is a venture capital firm, founded in 2018, focusing on investments in biotech, pharma, medtech, and artificial intelligence sectors in the Asia-Pacific region and the United States. It has invested in at least eight companies, including notable startups such as XtalPi. Its portfolio spans drug discovery, biotechnology, healthcare, and AI.

Industry: Investors

Partnerships

ZhenFundTencent HoldingsSequoia Capital ChinaSIG ChinaChina Life Healthcare Fund

Beyond the preview

Go deeper on Yael Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yael Capital.

Explore the full profile